Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SCINAI-IMMUNOTHERAPEUTICS-22054022/news/Ayana-Pharma-wahlt-die-CDMO-Einheit-von-Scinai-Immunotherapeutics-fur-die-Entwicklung-und-cGMP-Her-46398859/?utm_source=whatsapp&utm_medium=social&utm_campaign=share